IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v43y2023i5p595-609.html
   My bibliography  Save this article

General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations

Author

Listed:
  • Mathyn Vervaart

    (Department of Health Management and Health Economics, University of Oslo, Oslo, Norway)

  • Eline Aas

    (Department of Health Management and Health Economics, University of Oslo, Oslo, Norway
    Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway)

  • Karl P. Claxton

    (Centre for Health Economics, University of York, York, UK
    Department of Economics and Related Studies, University of York, York, UK)

  • Mark Strong

    (School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK)

  • Nicky J. Welton

    (School of Social and Community Medicine, University of Bristol, Bristol, UK)

  • Torbjørn Wisløff

    (Health Services Research Unit, Akershus University Hospital, Oslo, Norway)

  • Anna Heath

    (Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
    Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
    Department of Statistical Science, University College London, London, UK)

Abstract

Background Expected value of sample information (EVSI) quantifies the expected value to a decision maker of reducing uncertainty by collecting additional data. EVSI calculations require simulating plausible data sets, typically achieved by evaluating quantile functions at random uniform numbers using standard inverse transform sampling (ITS). This is straightforward when closed-form expressions for the quantile function are available, such as for standard parametric survival models, but these are often unavailable when assuming treatment effect waning and for flexible survival models. In these circumstances, the standard ITS method could be implemented by numerically evaluating the quantile functions at each iteration in a probabilistic analysis, but this greatly increases the computational burden. Thus, our study aims to develop general-purpose methods that standardize and reduce the computational burden of the EVSI data-simulation step for survival data. Methods We developed a discrete sampling method and an interpolated ITS method for simulating survival data from a probabilistic sample of survival probabilities over discrete time units. We compared the general-purpose and standard ITS methods using an illustrative partitioned survival model with and without adjustment for treatment effect waning. Results The discrete sampling and interpolated ITS methods agree closely with the standard ITS method, with the added benefit of a greatly reduced computational cost in the scenario with adjustment for treatment effect waning. Conclusions We present general-purpose methods for simulating survival data from a probabilistic sample of survival probabilities that greatly reduce the computational burden of the EVSI data-simulation step when we assume treatment effect waning or use flexible survival models. The implementation of our data-simulation methods is identical across all possible survival models and can easily be automated from standard probabilistic decision analyses. Highlights Expected value of sample information (EVSI) quantifies the expected value to a decision maker of reducing uncertainty through a given data collection exercise, such as a randomized clinical trial. In this article, we address the problem of computing EVSI when we assume treatment effect waning or use flexible survival models, by developing general-purpose methods that standardize and reduce the computational burden of the EVSI data-generation step for survival data. We developed 2 methods for simulating survival data from a probabilistic sample of survival probabilities over discrete time units, a discrete sampling method and an interpolated inverse transform sampling method, which can be combined with a recently proposed nonparametric EVSI method to accurately estimate EVSI for collecting survival data. Our general-purpose data-simulation methods greatly reduce the computational burden of the EVSI data-simulation step when we assume treatment effect waning or use flexible survival models. The implementation of our data-simulation methods is identical across all possible survival models and can therefore easily be automated from standard probabilistic decision analyses.

Suggested Citation

  • Mathyn Vervaart & Eline Aas & Karl P. Claxton & Mark Strong & Nicky J. Welton & Torbjørn Wisløff & Anna Heath, 2023. "General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations," Medical Decision Making, , vol. 43(5), pages 595-609, July.
  • Handle: RePEc:sae:medema:v:43:y:2023:i:5:p:595-609
    DOI: 10.1177/0272989X231162069
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X231162069
    Download Restriction: no

    File URL: https://libkey.io/10.1177/0272989X231162069?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Tiago M. Fragoso & Wesley Bertoli & Francisco Louzada, 2018. "Bayesian Model Averaging: A Systematic Review and Conceptual Classification," International Statistical Review, International Statistical Institute, vol. 86(1), pages 1-28, April.
    2. Laura Bojke & Marta O. Soares & Karl Claxton & Abigail Colson & Aimée Fox & Chris Jackson & Dina Jankovic & Alec Morton & Linda D. Sharples & Andrea Taylor, 2022. "Reference Case Methods for Expert Elicitation in Health Care Decision Making," Medical Decision Making, , vol. 42(2), pages 182-193, February.
    3. Anna Heath & Mark Strong & David Glynn & Natalia Kunst & Nicky J. Welton & Jeremy D. Goldhaber-Fiebert, 2022. "Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial," Medical Decision Making, , vol. 42(2), pages 143-155, February.
    4. Christopher Jackson & John Stevens & Shijie Ren & Nick Latimer & Laura Bojke & Andrea Manca & Linda Sharples, 2017. "Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods," Medical Decision Making, , vol. 37(4), pages 377-390, May.
    5. Briggs, Andrew & Sculpher, Mark & Claxton, Karl, 2006. "Decision Modelling for Health Economic Evaluation," OUP Catalogue, Oxford University Press, number 9780198526629.
    6. A. E. Ades & G. Lu & K. Claxton, 2004. "Expected Value of Sample Information Calculations in Medical Decision Modeling," Medical Decision Making, , vol. 24(2), pages 207-227, March.
    7. Anna Heath & Ioanna Manolopoulou & Gianluca Baio, 2018. "Efficient Monte Carlo Estimation of the Expected Value of Sample Information Using Moment Matching," Medical Decision Making, , vol. 38(2), pages 163-173, February.
    8. Mathyn Vervaart & Mark Strong & Karl P. Claxton & Nicky J. Welton & Torbjørn Wisløff & Eline Aas, 2022. "An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial," Medical Decision Making, , vol. 42(5), pages 612-625, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wei Fang & Zhenru Wang & Michael B. Giles & Chris H. Jackson & Nicky J. Welton & Christophe Andrieu & Howard Thom, 2022. "Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect Information," Medical Decision Making, , vol. 42(2), pages 168-181, February.
    2. Anna Heath & Mark Strong & David Glynn & Natalia Kunst & Nicky J. Welton & Jeremy D. Goldhaber-Fiebert, 2022. "Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial," Medical Decision Making, , vol. 42(2), pages 143-155, February.
    3. Anna Heath, 2022. "Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation," Medical Decision Making, , vol. 42(5), pages 626-636, July.
    4. Andrija S Grustam & Nasuh Buyukkaramikli & Ron Koymans & Hubertus J M Vrijhoef & Johan L Severens, 2019. "Value of information analysis in telehealth for chronic heart failure management," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-23, June.
    5. David Glynn & Georgios Nikolaidis & Dina Jankovic & Nicky J. Welton, 2023. "Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis," Medical Decision Making, , vol. 43(5), pages 553-563, July.
    6. Mathyn Vervaart & Mark Strong & Karl P. Claxton & Nicky J. Welton & Torbjørn Wisløff & Eline Aas, 2022. "An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial," Medical Decision Making, , vol. 42(5), pages 612-625, July.
    7. A C Bouman & A J ten Cate-Hoek & B L T Ramaekers & M A Joore, 2015. "Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-14, June.
    8. Chiranjeev Sanyal & Don Husereau, 2020. "Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 375-392, June.
    9. Xiaoyi Liu & Jonghyun Lee & Peter Kitanidis & Jack Parker & Ungtae Kim, 2012. "Value of Information as a Context-Specific Measure of Uncertainty in Groundwater Remediation," Water Resources Management: An International Journal, Published for the European Water Resources Association (EWRA), Springer;European Water Resources Association (EWRA), vol. 26(6), pages 1513-1535, April.
    10. Arantzazu Arrospide & Oliver Ibarrondo & Iván Castilla & Igor Larrañaga & Javier Mar, 2022. "Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity," Medical Decision Making, , vol. 42(2), pages 241-254, February.
    11. Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi, 2021. "Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 711-721, July.
    12. Kaitlyn Hastings & Clara Marquina & Jedidiah Morton & Dina Abushanab & Danielle Berkovic & Stella Talic & Ella Zomer & Danny Liew & Zanfina Ademi, 2022. "Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia," PharmacoEconomics, Springer, vol. 40(4), pages 449-460, April.
    13. Zhou, W. & O’Neill, E. & Moncaster, A. & Reiner, D. & Guthrie, P., 2019. "Applying Bayesian Model Averaging to Characterise Urban Residential Stock Turnover Dynamics," Cambridge Working Papers in Economics 1986, Faculty of Economics, University of Cambridge.
    14. Andrea Marcellusi & Raffaella Viti & Loreta A. Kondili & Stefano Rosato & Stefano Vella & Francesco Saverio Mennini, 2019. "Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data," PharmacoEconomics, Springer, vol. 37(2), pages 255-266, February.
    15. Risha Gidwani & Louise B. Russell, 2020. "Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers," PharmacoEconomics, Springer, vol. 38(11), pages 1153-1164, November.
    16. Roland Brown & Yingling Fan & Kirti Das & Julian Wolfson, 2021. "Iterated multisource exchangeability models for individualized inference with an application to mobile sensor data," Biometrics, The International Biometric Society, vol. 77(2), pages 401-412, June.
    17. Round, Jeff, 2012. "Is a QALY still a QALY at the end of life?," Journal of Health Economics, Elsevier, vol. 31(3), pages 521-527.
    18. He, Ni & Yongqiao, Wang & Tao, Jiang & Zhaoyu, Chen, 2022. "Self-Adaptive bagging approach to credit rating," Technological Forecasting and Social Change, Elsevier, vol. 175(C).
    19. Xinyue Dong & Xiaoning He & Jing Wu, 2022. "Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting," PharmacoEconomics, Springer, vol. 40(12), pages 1187-1205, December.
    20. Joseph F. Levy & Marjorie A. Rosenberg, 2019. "A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis," Medical Decision Making, , vol. 39(5), pages 593-604, July.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:43:y:2023:i:5:p:595-609. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.